Coronavirus impact: 29 April - surging profits and depression era declines
29/04/2020 · Alphabet (GOOGL) · Anpario PLC (ANP) · AstraZeneca (AZN) · Diaceutics PLC (DXRX) · EKF Diagnostics Holdings (EKF) · Fevertree Drinks (FEVR) · Next (NXT) · Novacyt SA (NCYT) · NWF Group (NWF) · Persimmon (PSN)
AIM AIM Inheritance Tax potential Coronavirus Dividends UK US
One of the world’s largest companies issued impressive results but the outlook is significantly more challenging. There was also some financial guidance at last from a small diagnostic group whose Covid-19 tests are in strong demand. Our latest update reveals more winners and losers from the current crisis
Alphabet: fabulous quarter but..
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREEDON'T MISS OUT ON OUR PREMIUM CONTENT
Become a champion investor for just £90 a year. Benefit from our high performing portfolios:
- Ultimate Stocks
- Income Boosters
- Mega Tends
- Bonkers Bargains
- Stonking Small Caps
- IHT qualifying selections
- ...and more
More on Alphabet
Ultimate Stocks Portfolio: encouraging updates lift shares
Plenty of news from our high-quality companies with our UK stars the standout performers here and…
Episode 39 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, hosts Chris and Lee dive into the controversial…
More on Anpario PLC
Coronavirus impact: 9 Sept - a day of concrete results
Plenty of results and plenty of positives from AIM companies to encourage
Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates
Cycling and video gaming are at opposite ends of the leisure spectrum, but both have benefited…
More on AstraZeneca
Overhyped perhaps - but don’t ignore AI!
Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…
AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?
The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…
More on Diaceutics PLC
Settlement disappoints | FDA approvals encourage
Updates covered here include news of a cash settlement for an unloved legal services business, a…
What is AIM’s exposure to Silicon Valley Bank?
One of AIM’s largest companies announced cracking full year results with a big increase in its…
More on EKF Diagnostics Holdings
Why bother with an update!
There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…
Coronavirus impact: 9 Nov – a renewable energy day
Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.
More on Fevertree Drinks
Episode 33 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, hosts Lee and Chris focus on news from…
US growth | Legal winner | Dividend delights
News covered here includes our assessment of interim results from Fevertree, which disappointed the market, despite…
More on Next
Episode 34 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, Chris and Lee discuss Next PLC's latest interim…
Episode 10 of the Investor’s Champion Podcast
This episode of the Investor's Champion Podcast discusses the value (or not) in automakers, Apple's lawsuits, Unilever's latest…
More on Novacyt SA
A refocused business delivers
Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…
Better than expected
Some welcome good news at last for shareholders in this provider of online competitions to win…
More on NWF Group
Big dividend appeal | More upgrades
Positive trading updates brought upgrades for two companies covered here while another offers a well-covered 6%+…
Upgrades and a big dividend payer
Results and updates from AIM covered here include excellent trading updates from two low profile businesses.…
More on Persimmon
Do our Income Boosters need a housebuilder?
With UK housebuilders offering yields up to 8%, should we add one to our Income Boosters dividend…
Income Boosters: Does our dividend portfolio need a housebuilder?
Housebuilders have become income favourites in recent years, but our income portfolio doesn't have any exposure…